Showing results (1051-1060 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|October 25, 2019
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatmentWayne J Aston, Danika E Hope, Alistair M Cook, et al.
Oncoimmunology|October 25, 2019
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profileRosa De Groot, Marleen M Van Loenen, Aurélie Guislain, et al.
Oncoimmunology|October 25, 2019
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumorsIoannis Kaffes, Frank Szulzewsky, Zhihong Chen, et al.
Oncoimmunology|October 25, 2019
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in miceSarah Lévesque, Julie Le Naour, Federico Pietrocola, et al.
Oncoimmunology|October 25, 2019
Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomasDaniëlle Verver, Vichnou Poirier-Colame, Gorana Tomasic, et al.
Oncoimmunology|September 2, 2025
Chronic antigen stimulation in melanoma induces T cell exhaustion and limits efficacy of T cell bispecific therapiesIdil Hutter-Karakoc, Eleni Maria Varypataki, Aparna Neelakandhan, et al.
Oncoimmunology|May 24, 2021
Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanomaXin-Wen Zhang, Katrin Huck, Kristine Jähne, et al.
Oncoimmunology|May 24, 2021
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1)Shu-Fen Chiang, Kevin Chih-Yang Huang, William Tzu-Liang Chen, et al.
Oncoimmunology|August 11, 2021
Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinomaR S A Goedegebuure, M Harrasser, L K de Klerk, et al.
Oncoimmunology|August 11, 2021
TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinomaGuoping Wang, Poorva Mudgal, Liuyang Wang, et al.
Pageof 379